Docosahexaenoic acid: a natural powerful adjuvant that improves efficacy for anticancer treatment with no adverse effects. - Wikidata - awgldk - TriplyDB

Docosahexaenoic acid: a natural powerful adjuvant that improves efficacy for anticancer treatment with no adverse effects.

Docosahexaenoic acid: a natural powerful adjuvant that improves efficacy for anticancer treatment with no adverse effects.

http://www.wikidata.org/entity/Q37950943

about

Docosahexaenoic Acid Induces Oxidative DNA Damage and Apoptosis, and Enhances the Chemosensitivity of Cancer Cells Omega-3 Fatty Acids and Cancer Cell Cytotoxicity: Implications for Multi-Targeted Cancer Therapy Alternative sources of n-3 long-chain polyunsaturated fatty acids in marine microalgae The omega-3 polyunsaturated fatty acid docosahexaenoic acid inhibits proliferation and progression of non-small cell lung cancer cells through the reactive oxygen species-mediated inactivation of the PI3K /Akt pathway Combination therapy with butyrate and docosahexaenoic acid for keloid fibrogenesis: an in vitro study Anti-cancer activities of ω-6 polyunsaturated fatty acids PPARδ signaling mediates the cytotoxicity of DHA in H9c2 cells.The janus face of lipids in human breast cancer: how polyunsaturated Fatty acids affect tumor cell hallmarks.Characterization of docosahexaenoic acid (DHA)-induced heme oxygenase-1 (HO-1) expression in human cancer cells: the importance of enhanced BTB and CNC homology 1 (Bach1) degradation.Omega-3 and Omega-6 Fatty Acids Act as Inhibitors of the Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 Activity.Synergistic anticancer properties of docosahexaenoic acid and 5-fluorouracil through interference with energy metabolism and cell cycle arrest in human gastric cancer cell line AGS cells.SOCS3 revisited: a broad regulator of disease, now ready for therapeutic use?Elimination of ALDH+ breast tumor initiating cells by docosahexanoic acid and/or gamma tocotrienol through SHP-1 inhibition of Stat3 signaling.Novel nanostructured lipid carrier co-loaded with doxorubicin and docosahexaenoic acid demonstrates enhanced in vitro activity and overcomes drug resistance in MCF-7/Adr cells.Distinct roles of different forms of vitamin E in DHA-induced apoptosis in triple-negative breast cancer cells.Docosahexaenoic acid (DHA) promotes immunogenic apoptosis in human multiple myeloma cells, induces autophagy and inhibits STAT3 in both tumor and dendritic cells.Knockdown of delta-5-desaturase promotes the anti-cancer activity of dihomo-γ-linolenic acid and enhances the efficacy of chemotherapy in colon cancer cells expressing COX-2.Dietary ω -3 polyunsaturated fatty acid DHA: a potential adjuvant in the treatment of cancer.Nanostructured Lipid Carrier Co-loaded with Doxorubicin and Docosahexaenoic Acid as a Theranostic Agent: Evaluation of Biodistribution and Antitumor Activity in Experimental Model.Model-driven discovery of long-chain fatty acid metabolic reprogramming in heterogeneous prostate cancer cells.Effect of cadmium exposure on essential omega-3 fatty acids in the edible bivalve Donax trunculus.Protective Effects of ω-3 PUFA in Anthracycline-Induced Cardiotoxicity: A Critical Review.Synergistic Effect of Eicosapentaenoic Acid on Antiproliferative Action of Anticancer Drugs in a Cancer Cell Line Model.Fish-Oil-Derived DHA-mediated Enhancement of Apoptosis in Acute Lymphoblastic Leukemia Cells is Associated with Accumulation of p53, Downregulation of Survivin, and Caspase-3 Activation.Phloridzin docosahexaenoate, a novel flavonoid derivative, suppresses growth and induces apoptosis in T-cell acute lymphoblastic leukemia cells.Polyunsaturated fatty acid-based targeted nanotherapeutics to enhance the therapeutic efficacy of docetaxel.Effects of the polyunsaturated fatty acids, EPA and DHA, on hematological malignancies: a systematic review.Omega-3 fatty acid DHA modulates p53, survivin, and microRNA-16-1 expression in KRAS-mutant colorectal cancer stem-like cells.Metastatic Brain Tumors Disrupt the Blood-Brain Barrier and Alter Lipid Metabolism by Inhibiting Expression of the Endothelial Cell Fatty Acid Transporter Mfsd2a.Sorafenib and docosahexaenoic acid act in synergy to suppress cancer cell viability: a role of heme oxygenase 1

P2860

Q26741436-2BC97422-F963-424E-B49A-ED920817F259 Q26773056-76AF399D-837F-4888-966A-09E91D586477 Q30651979-0CDC8F60-ED80-4BA6-9038-4E635698C583 Q33634757-9D2227C0-5B46-4274-AD88-3A8D859FACD0 Q33675721-B84D8BA4-9783-4828-A6F8-92867B306E07 Q34424444-9ECC9D8E-5AE3-4241-AB0E-08B15F2D0806 Q35802150-540A73CC-D163-411F-9AC9-3F68B6E14C08 Q36090372-42212994-42FA-475C-A39A-55DB274E2A32 Q37705221-B0BBA6FD-800B-4A19-BB70-8F296E1CCD82 Q38711191-B5A4FF12-5997-4F3C-A39F-E94F27B73EF6 Q38786634-560C0428-5D29-40C8-A145-FFBBF3D69424 Q38823319-D577F89E-4591-483E-9A85-6ADB57150E42 Q38913330-A2ED7BB1-1EFE-4065-AEC6-9C556011DA52 Q39024424-DA8384EA-F8C7-4F65-A392-18CD3B5CCB4D Q39329673-200088F6-5FC2-4383-924B-96FC8252F521 Q41785517-07A225E7-E7BA-4964-90D6-FF02CB9FF099 Q42123446-4E62361B-1503-4C67-9691-05B51E7C3A0D Q42146247-4B2115E6-571A-4F5A-8F6C-B7027DB7BC3E Q46209091-FF960135-107C-44C9-B9A2-95C0C163D871 Q47224220-266101E6-A848-42DE-B54C-ABFEE6E623A7 Q47769837-223E65E9-FD08-4563-AB7D-B56E7E93D457 Q47787078-82E652A6-3795-43B1-BE4F-D08E1B49EE51 Q47797570-4E5DEE4F-2442-47A0-9CB5-EE78F7A84694 Q48924805-F9E32FA9-9AFA-4E5B-BD5A-1C916D2F6445 Q50128979-68D026C3-DD07-4310-BE21-D03247B8005C Q50166313-66255D2F-66B1-46B7-B843-192C91F3D3DC Q52726199-2294BFBA-1966-4DC5-904C-A86DE5015286 Q55032187-4E0324EB-A9E0-4236-8EC6-6F43A00D0BC2 Q55295930-60AAD87D-8969-4AF4-BED5-B3613094FDE3 Q58112891-C756C1B1-CF64-4963-AF26-4E8D7ED50E9F

P2860

Docosahexaenoic acid: a natural powerful adjuvant that improves efficacy for anticancer treatment with no adverse effects.

http://www.wikidata.org/entity/Q37950943

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Docosahexaenoic acid: a natura ...... tment with no adverse effects.

@en

Docosahexaenoic acid: a natura ...... tment with no adverse effects.

@nl

type

label

Docosahexaenoic acid: a natura ...... tment with no adverse effects.

@en

Docosahexaenoic acid: a natura ...... tment with no adverse effects.

@nl

prefLabel

Docosahexaenoic acid: a natura ...... tment with no adverse effects.

@en

Docosahexaenoic acid: a natura ...... tment with no adverse effects.

@nl

P1433

Q37950943-9DC77BB1-DCAB-412C-81A5-53B944EC2E90

P1476

Q37950943-ADEBDBCD-0BD9-471F-9AAB-4A5C33E33503

P2093

Q37950943-517FC921-992B-40BC-BD97-3FB00B63FAE3

Q37950943-750550D2-4D62-473F-A9FF-F82DE3CC32A1

Q37950943-83662816-C639-4D0B-AABA-B2A6E6820932

Q37950943-A09E8FFA-A84E-47BC-8DD8-106BB7FD3AB4

Q37950943-AD864894-B084-4A43-B577-452B662D1261

Q37950943-AEE72467-B292-4457-A14A-D49A5EE891F2

P2860

Q37950943-01084C55-43F7-4390-B536-D640F95E5D6B

Q37950943-0377A5F9-9890-4F6D-A520-726D54CDFCE8

Q37950943-04F95CB5-D467-4B04-B497-CE5AB40AA608

Q37950943-066378E3-FD9F-4DC1-A31F-B1CD4B1E0CB7

Q37950943-0B04F9B3-D76A-447F-94B7-32377CF3D003

Q37950943-0F4B2A6C-429B-4A46-B167-687DBCB06A73

Q37950943-11D92F02-0DC1-445F-BE7F-17A705498970

Q37950943-16135D47-AC2A-4C53-85E2-F234F14D4771

Q37950943-173801A0-8A49-413E-9983-3950714D3C67

Q37950943-213C6B5D-F695-4C02-ACD3-E3BDAE700AFA

P304

Q37950943-B21BF95F-F5CA-40FB-87EA-E22819612A8E

P31

Q37950943-64EBE546-71AA-43E0-A8FA-9057DF4D3ACF

P356

Q37950943-5EFD50EF-0297-473F-9056-6201A091EADA

P433

Q37950943-DF11C62F-E8AE-45C3-9C8E-B77DEC657306

P478

Q37950943-8E3FC3AA-0502-458A-8EA8-C80006EC4BC5

P577

Q37950943-4D4A67A8-937B-49DD-80E3-B335ECC4EE28

P5875

Q37950943-B923DBBF-1CE2-454F-B139-724A3C181988

P698

Q37950943-A3558CBA-5B9E-4AD1-8556-CB9BC469FB21

P356

P1433

P1476

Docosahexaenoic acid: a natura ...... tment with no adverse effects.

@en

P2093

Candace Walker

http://www.w3.org/2001/XMLSchema#string

Elaine M Bammerlin

http://www.w3.org/2001/XMLSchema#string

Jeffrey D Altenburg

http://www.w3.org/2001/XMLSchema#string

Kevin A Harvey

http://www.w3.org/2001/XMLSchema#string

Rafat A Siddiqui

http://www.w3.org/2001/XMLSchema#string

Zhidong Xu

http://www.w3.org/2001/XMLSchema#string

P2860

Chemopreventive and renal protective effects for docosahexaenoic acid (DHA): implications of CRP and lipid peroxides

Arsenic trioxide induces apoptosis of myeloid leukemia cells by activation of caspases

Induction of cyclo-oxygenase-2 mRNA by prostaglandin E2 in human prostatic carcinoma cells

Genistein, daidzein, and their .beta.-glycoside conjugates: antitumor isoflavones in soybean foods from American and Asian diets

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

Effects of gamma-linolenic acid and oleic acid on paclitaxel cytotoxicity in human breast cancer cells.

1alpha,25-Dihydroxyvitamin D and fish oil synergistically inhibit G1/S-phase transition in prostate cancer cells.

Disruption of p53 in human cancer cells alters the responses to therapeutic agents

A synergistic antiproliferation effect of curcumin and docosahexaenoic acid in SK-BR-3 breast cancer cells: unique signaling not explained by the effects of either compound alone.

Docosahexaenoic acid: membrane properties of a unique fatty acid.

P304

399-412

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/BIOF.181

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P577

2011-10-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51753283

http://www.w3.org/2001/XMLSchema#string

P698

22038684

http://www.w3.org/2001/XMLSchema#string